secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001193125-24-162669
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus stockholders approve board declassification, annual director elections by 2026
--------------------------------------------------------------------------------

- Declassification Charter Amendment approved: 61,439,110 for, 135,200 against, 22,572 abstain.
- Board will shift to annual elections; entire board elected yearly starting 2026 annual meeting.
- Class III directors elected: Robert E. Claypoole, Philip G. Cowdy, Martin P. Sutter.
- Ratification of Grant Thornton as auditor for FY 2024: 71,179,096 for, 14,660 against.
- Amendment effective upon filing certificate of amendment with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000119312524162669/0001193125-24-162669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000119312524162669/d775079d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-162669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer